Alejandro Yacobitti1, Lisandro J Otero2, Valeria Soledad Doldan Arruabarrena3, Juan Arano4, Sergio Lage5, Martín Silberman6, Martín Zubieta7, Ilda Erbetta8, Patricia Danei9, Gertrudis Baeck10, Virgina Vallejos11, Federico Cavalli12, Nicolás Calderón13, Maximiliano Di Gregorio14, Viviana Hernández15, Daniela Bruno16, Beatriz Rodera17, David Parisi18, Ignacio Macherett19, Matías Gallastegui20, Andrea Paz21, Rubén Bernardi22, Sandra Azcárate23, A Hraste24, Inés Caridi25, Leonardo Boechi26, Silvia Kochen27. 1. Dirección de Gestión de Pacientes en Red Hospital El Cruce de Florencio Varela. ayacobitti@gmail.com. 2. Área de Planificación, Hospital El Cruce . lisandro.otero@gmail.com. 3. Área de Planificación, Hospital El Cruce . valeriadoldan@gmail.com. 4. Clínica médica, Hospital El Cruce . aranojm@gmail.com. 5. Terapia intensiva, Hospital El Cruce . bartolo185@gmail.com. 6. Consejo de administración Hospital el Cruce. silbermanmartin@gmail.com. 7. Laboratorio, Hospital El Cruce de Florencio Varela. mzubieta74@gmail.com. 8. Área administrativa, Módulo Hospitalario N° 11 de Florencio Varela. ildaerbetta@hotmail.com. 9. Área administrativa, UPA N° 11 de Florencio Varela. patricia.e.danei@gmail.com. 10. Ingreso de pacientes, Hospital Mi Pueblo de Florencio Varela. gertrudisvilmabaeck@gmail.com. 11. Unidad de Atención Inmediata, UPA N° 5 Almirante Brown. virginiavallejos0@gmail.com. 12. Área administrativa, UPA N° 5 y Módulo N° 9 de Almirante Brown. federicoacavalli@gmail.com. 13. Hospital Oñativia de Almirante Brown. nicolas-calderon@outlook.com. 14. Área administrativa, Hospital L. Meléndez de Almirante Brown. maximiliano.digregorio@gmail.com. 15. Hospital Oñativia de Almirante Brown. vgh_onativia@hotmail.com. 16. Área Estadística, Hospital Oñativia de Almirante Brown. danirobruno@gmail.com. 17. Clínica médica, Hospital Iriarte, Quilmes. bearodera@hotmail.com. 18. Unidad de Terapia Intensiva, Hospital Iriarte, Quilmes. davidjulioparisi@yahoo.com.ar. 19. Hospital Iriarte, Quilmes. macherett.in@gmail.com. 20. Director Hospital Oller. Quilmes. matigallas15@gmail.com. 21. Área administrativa, UPA N° 17, Quilmes. pazandr@gmail.com. 22. Unidad de Terapia Intensiva, Hospital Evita Pueblo, Berazategui. bernardiruben@hotmail.com. 23. Manejo de Pacientes, Hospital Evita Pueblo, Berazategui. sandra221261@gmail.com. 24. Hospital Evita Pueblo, Berazategui. ahraste@gmail.com. 25. Instituto de Cálculo, FCEN, UBA y CONICET. inescaridi@gmail.com. 26. Instituto de Cálculo, FCEN, UBA y CONICET. leonardoboechi@gmail.com. 27. ENyS, CONICET, Hosp. El Crucede Florencio Varela, Univ. Nacional A. Jauretche (UNAJ). skochen@gmail.com.
Abstract
Introduction: The present work describes the clinical characteristics and interventions to minimize morbidity and mortality in hospitalized patients diagnosed with COVID-19. Methods: It is a prospective cohort investigation of patients who received a response from the Health Centers in the southeast region (RS) of the metropolitan area (AMBA) from April 8 to September 30, 2020. A Situation Room was used epidemiological with two monitoring and follow-up boards, one for bed management and the other for patient management. Results: During the analyzed period, 2,588 patients with confirmed COVID-19 diagnosis were admitted, 1,943 with suspected COVID-19 pathology, and 1,464 subjects with other pathologies. 55% of the patients were men and the mean age was 51 years. There were 82.8% patients with pre-existing diseases, hypertension and diabetes were the most frequent. 14% were hospitalized in the Intensive Care Unit. The mortality of the cohort was 15.05%, mortality was higher for men, with a mean age of 60 years, 92.65% had some pre-existing disease. Conclusion: Our cohort is younger than other published works. Older people, men, and people with comorbidities are at increased risk for COVID-19-related mortality. The public health system was able to respond to the demand without collapsing the hospital institutions. Universidad Nacional de Córdoba
Introduction: The present work describes the clinical characteristics and interventions to minimize morbidity and mortality in hospitalized patients diagnosed with COVID-19. Methods: It is a prospective cohort investigation of patients who received a response from the Health Centers in the southeast region (RS) of the metropolitan area (AMBA) from April 8 to September 30, 2020. A Situation Room was used epidemiological with two monitoring and follow-up boards, one for bed management and the other for patient management. Results: During the analyzed period, 2,588 patients with confirmed COVID-19 diagnosis were admitted, 1,943 with suspected COVID-19 pathology, and 1,464 subjects with other pathologies. 55% of the patients were men and the mean age was 51 years. There were 82.8% patients with pre-existing diseases, hypertension and diabetes were the most frequent. 14% were hospitalized in the Intensive Care Unit. The mortality of the cohort was 15.05%, mortality was higher for men, with a mean age of 60 years, 92.65% had some pre-existing disease. Conclusion: Our cohort is younger than other published works. Older people, men, and people with comorbidities are at increased risk for COVID-19-related mortality. The public health system was able to respond to the demand without collapsing the hospital institutions. Universidad Nacional de Córdoba
Entities:
Keywords:
infecciones por coronavirus; investigación sobre servicios de salud; mortalidad
Authors: Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos Journal: JAMA Date: 2020-05-26 Impact factor: 56.272
Authors: Shruti Gupta; Salim S Hayek; Wei Wang; Lili Chan; Kusum S Mathews; Michal L Melamed; Samantha K Brenner; Amanda Leonberg-Yoo; Edward J Schenck; Jared Radbel; Jochen Reiser; Anip Bansal; Anand Srivastava; Yan Zhou; Anne Sutherland; Adam Green; Alexandre M Shehata; Nitender Goyal; Anitha Vijayan; Juan Carlos Q Velez; Shahzad Shaefi; Chirag R Parikh; Justin Arunthamakun; Ambarish M Athavale; Allon N Friedman; Samuel A P Short; Zoe A Kibbelaar; Samah Abu Omar; Andrew J Admon; John P Donnelly; Hayley B Gershengorn; Miguel A Hernán; Matthew W Semler; David E Leaf Journal: JAMA Intern Med Date: 2020-11-01 Impact factor: 21.873
Authors: Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti Journal: JAMA Date: 2020-04-28 Impact factor: 56.272
Authors: Mario Rivera-Izquierdo; María Del Carmen Valero-Ubierna; Juan Luis R-delAmo; Miguel Ángel Fernández-García; Silvia Martínez-Diz; Arezu Tahery-Mahmoud; Marta Rodríguez-Camacho; Ana Belén Gámiz-Molina; Nicolás Barba-Gyengo; Pablo Gámez-Baeza; Celia Cabrero-Rodríguez; Pedro Antonio Guirado-Ruiz; Divina Tatiana Martín-Romero; Antonio Jesús Láinez-Ramos-Bossini; María Rosa Sánchez-Pérez; José Mancera-Romero; Miguel García-Martín; Luis Miguel Martín-delosReyes; Virginia Martínez-Ruiz; Pablo Lardelli-Claret; Eladio Jiménez-Mejías Journal: PLoS One Date: 2020-06-25 Impact factor: 3.240
Authors: Betty Y Yang; Leslie M Barnard; Jamie M Emert; Christopher Drucker; Leilani Schwarcz; Catherine R Counts; David L Murphy; Sally Guan; Kosuke Kume; Karen Rodriquez; Tracie Jacinto; Susanne May; Michael R Sayre; Thomas Rea Journal: JAMA Netw Open Date: 2020-07-01
Authors: Christian Karagiannidis; Carina Mostert; Corinna Hentschker; Thomas Voshaar; Jürgen Malzahn; Gerhard Schillinger; Jürgen Klauber; Uwe Janssens; Gernot Marx; Steffen Weber-Carstens; Stefan Kluge; Michael Pfeifer; Linus Grabenhenrich; Tobias Welte; Reinhard Busse Journal: Lancet Respir Med Date: 2020-07-28 Impact factor: 30.700